MedTrace Logo

Deep Brain Stimulation for Treatment-Refractory Major Depression

NCT00122031 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 13

Last updated 2012-06-14

No results posted yet for this study

Summary

This study will investigate the use of deep brain stimulation (DBS) to reduce symptom severity and enhance the quality of life for patients with treatment-refractory major depression.

Conditions

Interventions

DEVICE

Deep Brain Stimulation with Medtronic Activa Neurostimulator

Deep brain stimulation (DBS) at 130 Hz

Sponsors & Collaborators

  • Medtronic

    collaborator INDUSTRY

  • University Hospital, Bonn

    lead OTHER

Principal Investigators

  • Thomas E Schlaepfer, MD · University of Bonn

  • Volker Sturm, MD · University of Cologne

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-07-31
Primary Completion
2009-04-30
Completion
2011-01-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00122031 on ClinicalTrials.gov